Evaluation of the rationality of clinical medication in diabetic microcirculation disorder
10.3969/j.issn.1006-5725.2018.09.029
- VernacularTitle:糖尿病微循环障碍临床用药合理性评价
- Author:
Xia TIAN
1
;
Juhong WEI
Author Information
1. 常熟市第一人民医院
- Keywords:
diabetic microcirculation disturbance;
microcirculation-improving drugs;
rational drug utilization
- From:
The Journal of Practical Medicine
2018;34(9):1524-1528
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the rationality about the application of clinical medication for diabetic microcirculation disorderturbance in a general hospital of level Ⅱ in Changshu. Methods Three hundred and fifty-nine patients with T2DM who received the clinical pathway treatment were enrolled in this study in a general hospital of level II in Changshu from July to December 2016. The statistical analysis was performed on the clinical application of microcirculation-improving drugs. The selection of microcirculation-improving drugs ,the drug utilization index(DUI),the intensity of microcirculation-improving drugs and the rate of drug combination were used as the evaluation criteria. Results The utilization rate of microcirculation-improving drugs was 94.43 %,and the combination rate was 73.75 %.The selection of microcirculation-improving drugs was the traditional Chinese medicine injections which activated blood circulation and vasodilators,with the DUI ranged from 0.9 to 1.1,and the intensity of microcirculation-improving drugs was 177.82 DDD. Conclusion The application of the clinical medication for the diabetic microcirculation disturbance was not standard,as a result,the indications of medication were not clear,and the indications of drug combination were not controlled strictly,the therapeutic regimen was unreasonable,and further management should be strengthened.
